| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/06/2013 | CN101584854B Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same |
| 02/06/2013 | CN101583366B Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 02/06/2013 | CN101549146B Romurtide injection and preparation method thereof |
| 02/06/2013 | CN101478950B Aqueous suspensions of TMC278 |
| 02/06/2013 | CN101336689B Caiguosu food and production method thereof |
| 02/06/2013 | CN101272762B Sachet formulation for amine polymers |
| 02/06/2013 | CN101227896B Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/05/2013 | US8367738 Smooth muscle contraction inhibitors |
| 02/05/2013 | US8367734 Stable epinephrine suspension formulation with high inhalation delivery efficiency |
| 02/05/2013 | US8367733 Composition for attenuation of pain or wound healing agents in dosage |
| 02/05/2013 | US8367652 Methods of treating hypertriglyceridemia |
| 02/05/2013 | US8367650 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 02/05/2013 | US8367635 Antimicrobial sucralfate paste methods and compositions |
| 02/05/2013 | US8367384 Bone semi-permeable device |
| 02/05/2013 | US8367118 Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/05/2013 | US8367117 Nanocomposite hyaluronic acid-clay based hydrogels |
| 02/05/2013 | US8367116 Buoyant polymer particles for delivery of therapeutic agents to the central nervous system |
| 02/05/2013 | US8367115 Process for production of crystalline cellulose and tablets containing granules |
| 02/05/2013 | US8367114 Method for preparing particles from an emulsion in supercritical or liquid CO2 |
| 02/05/2013 | US8367113 Polymers for functional particles |
| 02/05/2013 | US8367112 Nanoparticulate carverdilol formulations |
| 02/05/2013 | US8367111 beads/capsules; for treatment of cardiovascular disorders |
| 02/05/2013 | US8367110 Polymeric drug delivery compositions and methods for treating ophthalmic diseases |
| 02/05/2013 | US8367109 Microbes encapsulated within crosslinkable polymers |
| 02/05/2013 | US8367108 Hydrolyzable polyesters, polyurethanes, polyamideester copolymers, polyamides, and polyanhydrides; biodegradable, bioresorbable polymers for tissue engineering, implantable medical devices, and time-release drug delivery systems |
| 02/05/2013 | US8367107 Solid pharmaceutical preparation |
| 02/05/2013 | US8367106 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 02/05/2013 | US8367105 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 02/05/2013 | US8367104 Fast dissolving/disintegrating coating compositions |
| 02/05/2013 | US8367102 Pharmaceutical semi-solid composition of isotretinoin |
| 02/05/2013 | US8367101 Comprising plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising solid matrix of polymer which contains drug, sub-units being connected together in assembled dosage form by a weld |
| 02/05/2013 | US8367100 Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain |
| 02/05/2013 | US8367095 Two-piece, internal-channel osmotic delivery system flow modulator |
| 02/05/2013 | US8367089 Nanosilver coated bacterial cellulose |
| 02/05/2013 | US8367080 Pharmaceutical formulation for use in HIV therapy |
| 02/05/2013 | US8367079 Liquid preservative compositions |
| 02/05/2013 | US8367078 Kinase inhibitor compounds |
| 02/05/2013 | US8367077 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 02/05/2013 | US8367051 Preparation of functional gel particles with a dual crosslink network |
| 02/05/2013 | US8367044 Sunscreen cosmetic |
| 02/05/2013 | US8367043 Biologically active nanoparticles a carbonate-substituted hydroxyapatite, process for their preparation and compositions incorporating the same |
| 02/05/2013 | US8366973 Forming active material of copper/indium/gallium/selenium or sulfur as ink for solar cells by reacting a solution of non-oxide compounds and capping agent; annealing to form nanoparticles 1-500nm diameter; narrow size distribution; close packing; uniformity; polycrystalline; quality; high quality films |
| 02/05/2013 | US8366770 Biological artificial nerve guide and method of making |
| 02/05/2013 | US8366688 Non-discoloring sterilized wipe |
| 02/05/2013 | CA2723328C Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| 02/05/2013 | CA2718231C Emulsions including a peg-derivative of tocopherol |
| 02/05/2013 | CA2705063C Fast release solid formulation, preparation and use thereof |
| 02/05/2013 | CA2672551C Biodegradable block copolymeric compositions for drug delivery |
| 02/05/2013 | CA2665762C Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 02/05/2013 | CA2634479C Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same |
| 02/05/2013 | CA2620354C Des-c,d analogs of 1.alpha.,25-dihydroxy-19-norvitamin d3 |
| 02/05/2013 | CA2588880C Ophthalmic compositions comprising polyether substituted polymers |
| 02/05/2013 | CA2573985C A pharmaceutical composition comprising gabapentin |
| 02/05/2013 | CA2572127C Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 02/05/2013 | CA2542582C A mineralizing sheet for treatment of hypersensitive teeth having a surface covered with a prepreg having bioactive filler material |
| 02/05/2013 | CA2526099C Freeze-dried fsh / lh formulations |
| 02/05/2013 | CA2523475C Pharmaceutical formulation comprising a water-insoluble active agent |
| 02/05/2013 | CA2518903C Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 02/05/2013 | CA2512149C Film coated tablet comprising an extract of red vine leaves |
| 02/05/2013 | CA2507762C Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 02/05/2013 | CA2485116C Use of epa and dha in secondary prevention |
| 02/05/2013 | CA2479555C Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients |
| 02/01/2013 | CA2783917A1 Roll body of band-like patch |
| 01/31/2013 | WO2013016718A1 Compositions, process of preparation of said compositions and method of treating inflammatory diseases |
| 01/31/2013 | WO2013016697A2 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 01/31/2013 | WO2013016696A1 Antioxidant, neuroprotective and antineoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or an amphiphilic polymer |
| 01/31/2013 | WO2013016656A1 Sandalwood oil and its uses related to skin disorders |
| 01/31/2013 | WO2013016544A2 Templated islet cells and small islet cell clusters for diabetes treatment |
| 01/31/2013 | WO2013016511A1 Stable liquid formulations of volatile gas anesthetics |
| 01/31/2013 | WO2013016501A1 Formulations of thiophene compounds |
| 01/31/2013 | WO2013016494A1 Two part formulation system for ophthalmic delivery |
| 01/31/2013 | WO2013016427A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance |
| 01/31/2013 | WO2013016332A2 Composition and method for treating migraines |
| 01/31/2013 | WO2013016255A1 Wound-healing compositions and method of use |
| 01/31/2013 | WO2013016126A1 Therapeutic nanoparticles and methods of use thereof |
| 01/31/2013 | WO2013016125A1 Compositions and methods for the treatment of ocular surface allergies |
| 01/31/2013 | WO2013016006A1 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture |
| 01/31/2013 | WO2013015979A2 Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (vscs) |
| 01/31/2013 | WO2013015704A1 System for delivering biologically active agents into an organism and method for producing said system |
| 01/31/2013 | WO2013015685A1 Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds |
| 01/31/2013 | WO2013015634A2 Pharmaceutical composition for treating atopic dermatitis |
| 01/31/2013 | WO2013015599A2 Pharmaceutical composition for oral administration comprising bisphosphonic acid or its salt |
| 01/31/2013 | WO2013015578A1 Sustained release tablet comprising pregabalin through two-phase release-controlling system |
| 01/31/2013 | WO2013015545A1 Composition for edible film and pharmaceutical preparation for edible film containing drugs |
| 01/31/2013 | WO2013015541A1 Pharmaceutical formulations of bisphosphonate with enhanced oral bioavailability |
| 01/31/2013 | WO2013015419A1 Blood container for use in centrifuge |
| 01/31/2013 | WO2013014680A1 Method for treatment of pain and inflammation |
| 01/31/2013 | WO2013014677A1 Matrix compositions for controlled release of peptide and polypeptide molecules |
| 01/31/2013 | WO2013014476A1 Ear drop compositions and process for producing the ear drop compositions |
| 01/31/2013 | WO2013014473A1 Delivery of an active material |
| 01/31/2013 | WO2013014454A1 New (trimethoxyphenylamino)pyrimidinyl formulations |
| 01/31/2013 | WO2013014196A1 Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
| 01/31/2013 | WO2013014127A1 Polyacrylate-based active compound-comprising particles |
| 01/31/2013 | WO2013014098A1 Tampon having a hollow space |
| 01/31/2013 | WO2013014052A1 Composition |
| 01/31/2013 | WO2013013798A1 Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof |
| 01/31/2013 | WO2013013776A1 Prolonged release pharmaceutical composition comprising galantamine and method for the preparation thereof |
| 01/31/2013 | WO2013013657A1 Compressed solid pharmaceutical composition comprising amorphous particulate valsartan as the active ingredient |
| 01/31/2013 | WO2013013603A1 Livestock intestinal sustained-release anthelmintic and preparation method therefor |
| 01/31/2013 | WO2013013509A1 Rapid release-slow release osmotic pump preparation of compound methoxyphenamine |